EVOLENT HEALTH ($EVH) posted quarterly earnings results for Q3 2026 on Thursday, November 5th. The company reported earnings of $0.06 per share, beating estimates of $0.05 by $0.01. The company also reported revenue of $725,370,000, missing estimates of $731,428,264 by $-6,058,264.
You can see Quiver Quantitative's $EVH stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
EVOLENT HEALTH Insider Trading Activity
EVOLENT HEALTH insiders have traded $EVH stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $EVH stock by insiders over the last 6 months:
- DANIEL JOSEPH MCCARTHY (PRESIDENT) sold 65,892 shares for an estimated $329,460
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
EVOLENT HEALTH Hedge Fund Activity
We have seen 84 institutional investors add shares of EVOLENT HEALTH stock to their portfolio, and 103 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 3,925,979 shares (+36.1%) to their portfolio in Q2 2026, for an estimated $21,278,806
- NUVEEN, LLC added 2,866,943 shares (+1081.3%) to their portfolio in Q2 2026, for an estimated $15,538,831
- MARSHALL WACE, LLP added 2,628,233 shares (+334.8%) to their portfolio in Q2 2026, for an estimated $14,245,022
- MAVERICK CAPITAL LTD removed 2,572,763 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $13,944,375
- EVENTIDE ASSET MANAGEMENT, LLC removed 2,547,558 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $13,807,764
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 2,131,573 shares (+inf%) to their portfolio in Q2 2026, for an estimated $11,553,125
- UBS GROUP AG removed 1,905,078 shares (-23.4%) from their portfolio in Q2 2026, for an estimated $10,325,522
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
EVOLENT HEALTH Price Targets
Multiple analysts have issued price targets for $EVH recently. We have seen 3 analysts offer price targets for $EVH in the last 6 months, with a median target of $6.0.
Here are some recent targets:
- Jailendra Singh from Truist Securities set a target price of $7.0 on 06/30/2026
- Daniel Grosslight from Citigroup set a target price of $5.5 on 05/15/2026
- Richard Close from Canaccord Genuity set a target price of $6.0 on 05/12/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
